Pharma Companies May Benefit from Proposed Patent Law Changes in China; Public Comment Invited

By Philip Katz, Lu Zhou, Zhen Feng & Xin Tao

January 9, 2019

On January 4, China’s National People’s Congress (NPC) released draft amendments to the Chinese Patent Law, proposing expanded and enhanced protections that may provide real benefits to companies that develop new drugs. A potentially important condition to one of the key proposed changes specific to new drugs is that it would be available only for products that are submitted for marketing approval concurrently in China and other countries. Although clearly intended to motivate companies to…

Focus on Regulation

China Takes Significant Steps to Consolidate Generic Drug Industry and Lower Prices

By Xin Tao, Jim Johnson & Lu Zhou

December 10, 2018

With the opportunity for global pharmaceutical companies to gain new access to the Chinese market presenting itself like never before (see our previous blog posts here and here), significant news broke on December 7, 2018, regarding a newly implemented pilot centralized drug procurement program (the “program”) that will have significant ramifications for global pharmaceutical companies. Specifically, China just announced the reduction of prices for certain off-patent generic drugs by up to 96%. Under the…

Focus on Regulation

Real-name registration requirement imposed for civilian-use drones in China

By Tazewell Ellett, Lisa Ellman, Gretchen West, Andrew McGinty, Jun Wei & Lu Zhou

June 9, 2017

Following serious incidents of civilian drones entering the airspace of Chinese airports and causing flight delays last April, China’s civil aviation authority has issued the Real-name Registration of Civil Unmanned Aircraft Administrative Provisions, with effect from May 16, 2017, in an effort to increase accountability for drone use by requiring owners and manufacturers of civilian-use unmanned aircraft systems to complete “real-name” registration procedures.…

Global Media and Communications Watch

Now playing: New film law impacts the Chinese silver screen

By Sheri Jeffrey, Kevin Garland, Jun Wei, Lu Zhou & Nick Shaw

December 14, 2016

On November 7, 2016, the People’s Republic of China’s highest legislative body, the Standing Committee of the National People’s Congress, passed the Film Industry Promotion Law (Film Law). The Film Law takes effect on March 1, 2017. The Film Law is the first comprehensive “law” in China targeting the film industry specifically and is more than 13 years in the making. A “law” in China is a specific term for legislation passed at the national…

Global Media and Communications Watch

China Launches First Operational Rules for Civil Unmanned Aircraft

By Jun Wei, E. Tazewell Ellett, Lisa Ellman & Lu Zhou

January 21, 2016

China’s civil flight authority, the Civil Aviation Administration of China (CAAC), has issued new rules applicable to civil unmanned aircraft, commonly known as drones or UAS, weighing no more than 116 kg. The new rules are styled as the Provisions for the Operation of Light and Small Unmanned Aircraft (for Trial Implementation) (the UAS Operation Rules) and became effective on 29 December 2015, the date they were issued. The UAS Operation Rules add to a…

Lu Zhou

Pharma Companies May Benefit from Proposed Patent Law Changes in China; Public Comment Invited

China Takes Significant Steps to Consolidate Generic Drug Industry and Lower Prices

Real-name registration requirement imposed for civilian-use drones in China

Now playing: New film law impacts the Chinese silver screen

China Launches First Operational Rules for Civil Unmanned Aircraft

Stay Connected

Company

Support

New to the Network